$5.66
0.0951.71%
Last update: Nov 4, 1:14 PM
Cormedix Inc (CRMD) Stock Price, Quote, News & History
CRMDNASDAQ
CorMedix Q2 earnings beat estimates as sales more than doubled, DefenCath revenue grew, and the company reaffirmed 2026 sales guidance.
You can purchase shares of Cormedix (NASDAQ:CRMD) through any online brokerage.
Other companies in Cormedix’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Cormedix has a consensus price target of $15.33.
The stock price for Cormedix (NASDAQ: CRMD) is $5.655 last updated November 4, 2026 at 1:14 PM EST.
There are no upcoming dividends for Cormedix.
Cormedix does not have any upcoming earnings scheduled.
There is no upcoming split for Cormedix.
Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States...
